You are here

In the Media

Dr. Louis J. Aronne discusses a new weight loss treatment; a capsule intended to make people feel full faster by expanding after ingestion. Dr. Aronne was involved the clinical trials for the capsule, which was just approved by the Food and Drug Administration.

Dr. Anthony C. Watkins provides commentary on a study, published in the Annals of the American Osteopathic Association, which suggest that patients who are regular marijuana users may require higher levels of anesthesia during surgery.

A collaborative multi-center effort led by Dr. Nicholas Schiff demonstrated encouraging results for treatment of diminished executive function and fatigue in one patient suffering from moderate to severe traumatic brain injury. The early stage results were presented during The BRAIN Initiative Investigator’s Meeting, sponsored by the National Institutes of Health.

Khadijah Sabir, a 10-year-old Weill Cornell Medicine patient, whose search for a donor was profiled last month, celebrated her 10th birthday with her classmates. During the festivities, Khadijah’s family announced that they have found a donor match as a direct result of the original segment.

Dr. Christopher E. Mason discusses the results of the NASA Twins study, published in Science, in which he led one of the research teams chosen by NASA. The study explored the long-term health effects of living in space by studying blood samples of astronaut twin brothers Mark and Scott Kelly.

Dr. Conor Liston's new study, published in Science, found that the powerful but temporary benefits of ketamine against depression may be maintained if the neural connections the drug helps promote is preserved.

A new artificial intelligence approach developed by Weill Cornell Medicine investigators has proven to be able to optimize embryo selection for in-vitro fertilization. The findings by researchers from the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine and the Caryl and Israel Englander Institute for Precision Medicine are published in NPJ Digital Medicine.

A feature on international medical students in the U.S. mentions a visiting student who completed a clinical elective at Weill Cornell Medicine. Dr. Madelon L. Finkel provides commentary on the application process through the Office of Global Health Education at Weill Cornell.

Weill Cornell Medicine has been selected as a contender in the annual STAT Madness competition, a March Madness-inspired, bracket-style contest to honor innovation in science and medicine. Hosted by STAT, a national online news outlet affiliated with The Boston Globe. Online voting opens Monday, March 4.

Dr. Jean W. Pape’s efforts to confront Haiti's health challenges for the past several decades are highlighted in a PBS NewsHour special. His collaboration with Dr. Warren Johnson at Weill Cornell Medicine on the creation of GHESKIO is also mentioned.

Dr. Jean W. Pape’s efforts to confront Haiti's health challenges for the past several decades are highlighted in a PBS NewsHour special. His collaboration with Dr. Warren Johnson at Weill Cornell Medicine on the creation of GHESKIO is also mentioned.

Dr. Setareh Salehi Omran’s study, published in the journal, Stroke, found that the rate of hospitalizations for stroke rose 20 percent per year between 2008 and 2015, coinciding with the worsening of the opioid epidemic. The study showed these strokes were among complications of injecting opioids.

Weill Cornell Medicine and New York-Presbyterian announced the opening of a new multispecialty practice in Long Island City. The office is expected to open next year and will include internal medicine, pediatrics, OB/GYN and rotating specialty services.

An article on the importance of learning portion control to lose or maintain weight mentions Dr. Sylvia R. Karasu’s book “Of Epidemic Proportions: Expanded Edition 2019,” which discusses the science of obesity and weight control.

Dr. Robert S. Brown provides commentary on a study, published in JAMA Internal Medicine, which found that alcohol-associated liver disease now edges out hepatitis C as the No. 1 reason for liver transplants in the United States.

Dr. Jeffrey M. Perlman’s former patient, Isabella Ciriello, plays the guitar for infants in the newborn intensive care unit (NICU) at NewYork-Presbyterian and Weill Cornell Medicine. Isabella was treated in the same facility by Dr. Perlman when she was born almost 16 weeks prematurely.

Weill Cornell Medicine and NewYork-Presbyterian hosted their annual Cabaret benefit dinner, which raised more than $4 million to support the institutions’ ongoing work in patient care, research and medical education.

Drs. Sean M. Murphy and Bruce Schackman’s new study, published in Annals of Internal Medicine, found that treating opioid use disorder (OUD) in adults with a daily medication is more cost-effective than a monthly injection.

Dr. Heather Yeo’s new research letter, published in JAMA Surgery, found that a stigma continues to exist about bariatric surgery for weight loss. Nearly 40 percent of those surveyed felt this surgery was a “lazy, quick fix” for weight loss.

Dr. Andrew J. Dannenberg’s new study, published in JAMA Oncology, found that older women with excess body fat could be at greater risk for breast cancer, even if they are considered to be at normal body-mass index.

An article tells the story of Dr. Mark M. Souweidane's 4-year-old patient Natan, who was diagnosed with a slow-growing brain tumor known as ganglioglioma. After a successful surgery and ongoing promising treatment, nearly all of Natan’s detectable tumor is now gone.

Dr. Nicholas D. Schiff’s new study, published in Current Biology, found that measuring brain activity in response to hearing a brief narrative can identify patients with severe brain injury who have preserved high-level cognition despite showing limited or no consciousness at the bedside.

Dr. Jessica M. Peña authors an editorial on her experience as an underrepresented minority in medicine and how Weill Cornell Medicine’s Health Profession Recruitment/Exposure Program helped her succeed in her career.

Dr. Laura Riley provides commentary on a study, published in JAMA Internal Medicine, which found that women and their babies face certain health risks when the interval between consecutive pregnancies is less than 12 months.

Dr. Ronald G. Crystal discusses his attempt to climb Mount Everest earlier this year and the subsequent pulmonary condition he experienced. He also discusses the importance of having goals and staying active as you age.

A video series by filmmaker and journalist Nicole Ellis on her personal journey of exploring fertility options. One episode features Dr. Elizabeth Grill, who discusses various types of counseling to help with life’s major decisions.

Dr. Lisa Newman provides commentary on a study, published in the Journal of the National Cancer Institute, which found that close relatives of cancer patients would be more willing to be tested for a genetic mutation that puts them at risk, if testing is accessible and affordable.

Dr. Irina Sobol provides commentary on a study, presented at the European Society of Cardiology Congress and published in the New England Journal of Medicine, which found that patients with a rare condition that can lead to heart failure lowered their risk of dying by 30 percent after being treated with Pfizer’s tafamidis.

An article highlights Dr. Avital Falk’s program, the Weill Cornell Pediatric OCD, Anxiety, and Tic Disorders Program (POCAT). Growing new research suggests that short, intense courses are generally just as effective, and in some ways more effective, as treatment that is spread out over several months.

Dr. Christopher E. Starr comments on a new study, published in Scientific Reports, which found that the glow emitted from most smartphones, tablets and laptops — promotes the growth of “poisonous molecules” in the eyes, leading to macular degeneration.

Dr. Laura Riley has been appointed chair of the Department of Obstetrics and Gynecology at Weill Cornell Medicine and obstetrician and gynecologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective October 1.

Dr. Costantino Iadecola provides commentary on a study, published in the New England Journal of Medicine, which found that targeting a lower blood pressure goal may decrease risk for developing memory problems and cognitive difficulties that precede decline into life-altering dementia.

Dr. Jaclyn H. Bonder provides commentary on a study, published in the American Journal of Obstetrics and Gynecology, which found that careful assessment of pain during palpation of pelvic muscles can help to clarify the diagnosis of pelvic floor myofascial pain.

Dr. Lewis C. Cantley’s new study, published in Nature, showed how the combination of a ketogenic diet with a type of cancer drug called a PI3K inhibitor, strongly improves the performance of the drug in mouse models.

Dr. Li Gan was appointed the new Director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine. The institute is dedicated to understanding the molecular, cellular and genetic underpinnings of Alzheimer’s disease and related degenerative neurological disorders to benefit patient care.

Dr. Adam D. Talenfeld’s study, published in the Annals of Internal Medicine, found that a procedure, known as percutaneous ablation, may result in long-term survival equal to that of surgery for patients with kidney cancer.

Wolf Blitzer tells the story of his mother’s dementia and discusses Dr. Ronald Crystal’s research on a gene therapy that targets the ApoE gene, which physician-scientists use to assess people's risk of developing Alzheimer's.

Dr. Bilal Cughtai provides commentary on a study, published in Urology, which found that men with stress urinary incontinence (SUI) tend to wait years before deciding to have anti-incontinence surgery.

Dr. Ruth Gotian will lead Weill Cornell Medicine's newly established Mentoring Academy, a leadership development program for the institution's faculty. Dr. Ruth Gotian will also be the chief learning officer of the department of anesthesiology.

An article on the decline of U.S. cancer mortality due to better prevention, earlier detection, and improved genetic knowledge and treatment, mentions Dr. Theodore Schwartz’s study, published in the Journal of Neurosurgery. The study found that Cesium-131 brachytherapy implants result in less damage to healthy brain tissue than whole-brain radiation or highly focused radiosurgery.

A research center in collaboration with Weill Cornell Medicine and The Physicians Foundation aims to ensure rules, regulations and requirements in medical practice are achieving the best outcome for patients.

Coverage announcing that the Weill Cornell Medicine BioVenture e-Lab will hold its second annual Biomedical Business Plan Challenge on May 9. Scientists will pitch business plans in a competition for $100,000 in funding and $35,000 in legal services to help them commercialize their ideas and technology.

Dr. Christopher E. Mason led a research project at the annual Milken conference, which gathered microbial data to help create the first global map to track hot spots of resistance to antibiotics. The article also mentions the collaboration between Weill Cornell Medicine and WorldQuant to accelerate research in the fields of computational biomedicine and genomics.

Dr. Mario Gaudino’s analysis, published in the New England Journal of Medicine and presented at the American Association Thoracic Surgery’s annual meeting, suggests that radial artery grafts are far superior to saphenous vein grafts for coronary artery bypass surgery.

Dr. Nasser K. Altorki provides commentary on two studies, published in The New England Journal of Medicine and presented at the annual meeting of the American Association for Cancer Research, which found that combining new immune-boosting cancer drugs with each other or with older drugs improved survival in patients with lung cancer, compared with traditional chemotherapy.

Dr. Lisa Mosconi discusses how water consumption and diet can affect the brain, based on her recently published book. The article also mentions Dr. Mosconi has received a five-year grant from the NIH to study Alzheimer’s and women’s brains.

Dr. Norman Sharpless, the National Cancer Institute Director of the National Institutes of Health, gave a presentation at Weill Cornell Medicine in which he discussed the future of cancer treatments. The presentation was part of the NCI Director’s visit to the Meyer Cancer Center, where he met with cancer center leadership and toured the labs.

An article on the usage of “mosaic” embryos containing normal and abnormal cells, mentions Dr. Glenn L. Schattman’s editorial, which found that embryos with up to 50% of abnormal cells implanted at the same rate as those that tested as normal. Dr. Schattman’s editorial accompanied a study, published in Fertility and Sterility in January, which evaluated how many mosaic embryos resulted in the births of healthy babies.

Dr. Anthony Hollenberg discusses his research and goals as the new chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian.

Weill Cornell Medicine and Cornell University announce the opening of the Cornell Center for Health Equity, a center which will explore why health outcomes vary among different demographic groups by conducting research in New York communities. Dr. Monika M. Safford and Dr. Avery August are co-directors of the center.

Dr. Christopher E. Mason appears on CBS This Morning to swab some common workplace areas where viruses and bacteria – including the flu – might be hiding. He discusses the hot-spot areas where you might find the most microbes and influenza such as door handles, the kitchen sink, and elevator buttons.

Dr. Olivier Elemento discusses his vision as the new Director of the Caryl and Israel Englander Institute for Precision Medicine. Dr. Elemento detailed his plans to continue expanding the Institute’s whole-exome and whole-genome sequencing to advance scientific knowledge and create personalized therapy for patients with cancer.

Dr. Augustine M.K. Choi authors an op-ed on how stricter immigration controls and rescinding the Deferred Action for Childhood Arrivals (DACA) will affect patients, medical education, and biomedical research in the United States.

Dr. Erica C. Jones provides commentary on a new study, published in The New England Journal of Medicine, which suggests that the risk of heart attack is six times greater than normal when people are ill with the flu.

Analise Scarpaci, a young patient under the care of Dr. Robbyn Sockolow, discusses how the treatment she received at Weill Cornell Medicine and NewYork-Presbyterian allowed her to pursue her dreams of becoming a Broadway actress. Analise’s story was highlighted during the annual Cabaret benefit dinner.

Dr. Costantino Iadecola’s new study, published in Nature Neuroscience, found that a high-salt diet reduces resting blood flow to the brain and causes dementia in pre-clinical settings. The study is the first to unveil a gut-brain connection linking high dietary salt intake to neurovascular and cognitive impairment.

Dr. Virginia Pascual pens an editorial on the lack of pediatric research and how it can be addressed. “The Gale and Ira Drukier Institute for Children’s Health is bringing together the best physician-scientists with a laser focus on childhood diseases. It is developing advanced methods of studying diseases in children, using big data and computational biology,” writes Dr. Pascual.

Dr. Virginia Pascual discusses her presentation at the American College of Rheumatology (ACR) annual meeting about precision medical care for rheumatic diseases, as well as advancements in biomarker identification in systemic lupus erythematosus (SLE).

Dr. Howard A. Fine discusses the creation of “mini-brains” in his laboratory to study the development and treatment of brain tumors, such as glioblastoma. Dr. Fine is one of the few scientists using the organoids to research brain cancer in hopes of personalizing glioblastoma care to an unprecedented degree.

Dr. Anthony Hollenberg, a physician-scientist specializing in endocrinology, has been appointed chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at New York-Presbyterian/Weill Cornell Medical Center, effective February 1.

Dr. Daniel Fitzgerald, an international leader in infectious diseases, has been named the new director of the Center for Global Health at Weill Cornell Medicine. He replaces the center's founding director, Dr. Warren Johnson, who will focus on training and mentoring junior faculty and fellows.

Dr. Richard S. Isaacson discusses why women are at higher risk than men to get Alzheimer’s disease and his upcoming new study about developing effective treatments against the disease. The segment kicks off NBC’s series “Brain Power,” which will air during November as Alzheimer’s Awareness Month.

Dr. Howard A. Fine has been awarded a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer research. Established in 2004, NIH Director’s Pioneer Awards, part of the NIH Common Fund, will provide nearly $1.2 million annually for five years to a single principal investigator who has demonstrated exceptional creativity and is pursuing a bold new research strategy against a major biomedical challenge.

Weill Cornell Medicine’s Clinical and Translational Science Center received a $45.3 million renewal of its funding from the National Institutes of Health through 2022. The center, which supports translating research into treatments for patients, is a consortium that includes participation from NewYork-Presbyterian Hospital, Cornell University, Memorial Sloan Kettering Cancer Center, Hospital for Special Surgery, CUNY Hunter College and Animal Medical Center.

Dr. Nicholas Schiff provides commentary on a new study, published in the journal Current Biology, which details that electrically stimulating the vagus nerve helped in restoring some signs of consciousness in a brain-injured man who had not shown any awareness in 15 years.

Dr. Art Sedrakyan’s new study, published in Health Services Research, found that actress Angelina Jolie’s 2013 announcement detailing her decision to undergo a mastectomy to reduce her risk of developing breast cancer likely inspired more women in English-speaking countries to do the same.

Dr. Olivier Elemento has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine. He will also lead joint precision medicine efforts at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

Weill Cornell Medicine has announced a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant, awarded by the National Cancer Institute. The grant funding will be used to improve the detection, diagnosis and treatment of prostate cancer

Dr. Howard Fine discusses the creation of “mini-brains” in his laboratory, which are being used to better study the development of brain tumors, such as glioblastoma. "The one thing I know about this disease, is we can't keep doing the same thing. Until our patients are cured of this disease, I'm not satisfied," Dr. Fine said.

Dr. Roy M. Gulick’s new study, published in Annals of Internal Medicine, finds that maraviroc-containing regimens appear to be safe and well tolerated, compared with tenofovir-emtricitabine (TDF-FTC), for preventing HIV infection in women.

Weill Cornell Medicine announced the appointment of Dr. Robert Min as President and Chief Executive Officer of the Physician Organization, effective January 1, 2018. In addition, Weill Cornell Medicine announced the appointment of Dr. Adam Stracher as Chief Medical Officer and Associate Dean for Clinical Affairs.

Dr. Peter N. Schlegel discussed a study, published in Human Reproduction Update, which found that sperm counts in Western countries have decreased by half in recent years, suggesting a continuing and significant decline in male reproductive health.

Dr. Barry Kosofsky provided commentary on young children participating in contact football, in light of a recent study, published in the Journal of the American Medical Association (JAMA), which found that 110 out of 111 deceased N.F.L. players suffered from minor to severe chronic traumatic encephalopathy.

Dr. Philip O. Katz wrote an editorial accompanying a study, published in the Lancet Gastroenterology & Hepatology, which found that esophageal manometry with a solid test meal instead of single water swallows better diagnoses esophageal motility disorders.

Dr. Todd S. Cutler discussed rhabdomyolysis, a rare but life-threatening condition often caused by extreme exercise. His 2016 study, which analyzed the amount of emergency room visits for exercise-induced rhabdomyolysis, was also mentioned.

Dr. Monika M. Safford’s latest study, published in Circulation, found that African-American adults are more likely than whites to die of a first heart attack. The findings indicated that the likelihood of a fatal first attack may stem from heart risk factors and the conditions in which people are born, grow, work and live.

Dr. Mirella Salvatore discusses the importance of scheduling a health consultation well in advance when traveling internationally to ensure your immunizations are effective and to allow time for additional doses if needed.

Dr. Ashish Raj’s new study, published in PLoS Computational Biology, used mathematics and a form of magnetic resonance imaging to better understand how neurological disorders affect the connections between the brain’s deep white matter and its network of fibers.

Dr. Claire Henchcliffe discusses advances and revisions made in the use of stem-cell transplants as a treatment for Parkinson’s disease during the annual International Society for Stem Cell Research meeting.

Dr. Jonathan Zippin provides commentary on a study, published in Cell Reports, which found a successful way of darkening the pigmentation of human skin cells by applying an enzyme called small-molecule salt-inducible kinases. The darkened pigmentation may protect against the type of UV damage that can lead to skin cancer.

An article about a study that examines the use of anesthetic injections to alleviate symptoms of post-traumatic stress disorder includes research by Dr. JoAnn Difede on the effectiveness of the most common psychological treatments for combat-related PTSD.

Dr. Joshua A. Halpern’s new study, published in JAMA Internal Medicine, found that combining kidney ultrasound with cystoscopy appears to be the most cost-effective way to screen for cancers of the genitourinary tract in patients with asymptomatic microscopic hematuria.

An article on studies presented during the American Association for Cancer Research annual meeting highlights Dr. Andrew J. Dannenberg’s new study, published in Cancer Prevention Research. Dr. Dannenberg’s study found that women with a healthy body mass index may be at risk of developing breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process.

Dr. Joshua Milner, chief of the Genetics and Pathogenesis of Allergy Section at the National Institute of Allergy and Infectious Diseases, has been awarded the second annual Gale and Ira Drukier Prize in Children’s Health Research.

Dr. Marisa A. Censani’s latest study, presented during ENDO 2017, found that vitamin D deficiency was associated with early markers of cardiovascular disease in overweight and obese children and adolescents.

Dr. Rainu Kaushal provides commentary on an increase in graduate programs being introduced to better prepare students to tackle health care's biggest challenges. The new dual-degree program offered by Weill Cornell Medicine and The Samuel Curtis Johnson Graduate School of Management is mentioned.

Dr. Richard T. Silver provides commentary on the results of a phase III trial, published in the New England Journal of Medicine, which found that the cancer drug imatinib (Gleevec) helped more than 80% of patients with chronic myelogenous leukemia remain alive for almost 11 years.

A new study by Weill Cornell Medicine researchers, led by Dr. Hugh C. Hemmings Jr., published in the Proceedings of the National Academy of Sciences, found that anesthesia induces unconsciousness by changing the function of proteins that reside on the surface of a thin membrane that forms a barrier around all cells. The findings debunk a century-old concept of how anesthesia works and may help guide the development of new agents associated with fewer side effects.

Weill Cornell Medicine hosted their annual Healthy Living Symposium and reception on the latest in preventive medicine to Palm Beach area residents. Dr. Augustine Choi moderated the panel and presentations were given by Drs. Robert S. Brown, Himisha Beltran and Leonard N. Girardi.

Bionic Sight, a startup company founded by Dr. Sheila Nirenberg, has announced plans to start clinical trials to treat blindness by 2018. The cutting-edge treatment involves combining an emerging technology called optogenetics, a form of gene therapy, with high-tech goggles to stimulate the ganglion cells inside the eye.

Weill Cornell Medicine has entered a three-year alliance German drugmaker Boehringer Ingelheim to research new treatment options for chronic obstructive pulmonary disease. The agreement will allow Weill Cornell’s Department of Genetic Medicine to combine its expertise with Boehringer Ingelheim’s ability to discover and develop new drugs for respiratory diseases.

Dr. Gail M. Saltz provides commentary on research, published by the American Academy of Pediatrics, which suggests that routinely sitting down for family meals may be beneficial in helping bolster kids’ social skills while improving their eating habits.

Weill Cornell Medicine received a $12.5 million gift from the Feil family to establish the Feil Family Student Center. The 16,200 square foot student center will include space for instruction, study and collaboration, increasing the area dedicated to student activities by 75 percent. Raul J. Martinez-McFaline notes: “The direction we’re going in is a team-based approach, and this student center will really allow for that.”

Dr. Robert S. Brown provides commentary on a study, published by the Institute for Safe Medication Practices, which found that drugs approved in recent years that can cure hepatitis C may have severe side effects, including liver failure.

Dr. Augustine M.K. Choi, an internationally renowned physician-scientist in the field of lung disease, has been named the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Cornell University’s provost for medical affairs. Dean Choi has served as the interim dean since last June and notes that it is a “big job, an impactful job. I’m here for the challenge.”

Kevin O’Rourke, an MD-PhD candidate at Weill Cornell Medicine was chosen as one of Forbes 30 Under 30 for his research studying colorectal cancer. His study, published in Cell in 2015, found that a gene called APC caused colorectal cancer in mice.

Dr. Harold E. Varmus is mentioned as the co-chair of a new Life Sciences Advisory Council formed as part of Mayor Bill de Blasio’s plan to invest $500 million over 10 years in New York City’s life sciences sector.

Dr. Richard S. Isaacson provides commentary on a study, published in JAMA Neurology, which found that regular use of statins, a class of drugs used to reduce low-density lipoprotein, is associated with a reduced risk for Alzheimer’s.

Dr. Conor Liston discusses his new study, published in Nature Medicine, which found that depression can be grouped into different subtypes as defined by distinct patterns of abnormal connectivity in the brain seen on functional MRI (fMRI).

Dr. Nicholas D. Schiff and Daniel Thengone’s study, published in Science Translational Medicine, recounts the success of a woman with a severe brain injury who recovered the ability to communicate using her left eye. This is the first time that scientists have documented the restoration of communication of a minimally conscious patient.

Dr. John P. Leonard discusses his phase 3 multicenter study at the ASH Annual Meeting, which found that dose-adjusted R-EPOCH chemotherapy did not appear superior to standard chemoimmunotherapy for the treatment of patients with diffuse large B-cell lymphoma.

Dr. Amos Grunebaum’s new study, published in the Journal of Perinatal Medicine, found when U.S. babies die during home births, the cause is most often labor and delivery complications, birth defects or infections, with the death rate for midwife-attended home births to be almost 13 fatalities for every 10,000 deliveries.

Dr. Linda T. Vahdat discusses improving survival rates for metastatic breast cancer and her clinical trial, which found that tetrathiomolybdate, a copper depletion compound, was able to stop the spread of metastatic tumors in high risk breast cancer patients.

Joan Weill and Dr. Barry Kosofsky appear as guests on CNBC to discuss the Women’s Health Symposium and preventative care for concussions amongst athletes based on research conducted at Weill Cornell Medicine. Dr. Gregory A. Petsko’s Alzheimer’s research and participation with the Women’s Health Symposium is highlighted.

Dr. Michael G. Kaplitt appears as a guest on the Charlie Rose Show to discuss the use of high intensity focused ultrasound (HIFU) to alleviate the symptoms of essential tremors. His patient, Alex Lebenthal, who has had essential tremor since the age of 3, recently underwent the procedure and is now able to do things she never thought possible, such as drink coffee with one hand and write her name.

Dr. Costantino Iadecola discusses his new report in association with the American Heart Association, which found that high blood pressure during middle age is associated with an increased risk of cognitive decline later on. “Hypertension is the worst thing that could happen to the brain. Less blood gets to the brain, because the vessels become thicker and less able to deliver the blood that the brain needs to function,” Dr. Iadecola said.

Dr. George S. Alexopoulos provides commentary on a study, published in The Lancet, which found that both cognitive-behavioral therapy and behavioral-activation therapy were equally effective treatments for depression.

Drs. Silvia C. Formenti, David M. Nanus, and Gail J. Roboz are featured as part of ABC 7’s half hour special presentation on cancer research conducted at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

Veracyte, Inc. presented new data indicating that its in-development genomic test, the Envisia classifier, has the potential to diagnose idiopathic pulmonary fibrosis (IPF), distinguishing it from other interstitial lung diseases (ILD), and reduce the need for invasive diagnostic surgeries.

Throughout the arc of human history, sleep has been a mysterious process that has captured the imaginations of both artists and scientists. Researchers are slowly deciphering how sleep restores us, and how its woeful absence makes us ill.

Communication about end-of-life care can improve how likely Latino patients with terminal cancer are to sign a do-not-resuscitate (DNR) order, helping to close the gap with white patients, according to research by Weill Cornell Medicine scientists.

Twins born minutes apart may be eerily similar or just as eerily different. Even if they are not identical, they share yards of genetic material, and yet one turns out large and one small, one strong and one weak, one a poet and the other a mumbler.

We see these disparities in people all the time. And now we see them in a pair of books on the gene, published on the same day. Sharing yards of genetic material, both works aim to explain the power and mystery of the human genome, yet could not be more different.

Dr. Adriana Rossi discusses the “revolutionary” advances being witnessed in terms of clinical approaches for the treatment of multiple myeloma. “Every year we’re really making huge progress — not only in understanding the pathophysiology of the disease but actually translating that into new therapies,” Dr. Rossi stated.